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Introduction
The vertebrate immune system is a finely tuned and 
remarkably flexible instrument of host defense. A 
combination of innate pathogen associated molecular 
pattern recognition and the astonishing diversity and 
specificity of adaptive immunoreceptors provides protection 
from omnipresent and ever-changing pathological insults. 
From viruses to bacteria to eukaryotes to cancer, the 
diversity and abundance of potential threats that we are 
constantly encountering is a testament to our immune 
system’s protective capacity.
CD8+ T cells are adaptive immune cells with an 
exceptional ability to specifically recognize and kill cells 
presenting foreign antigens (1). Each CD8+ T cell expresses 
just one of over a thousand trillion possible versions of 
the T cell receptor (TCR) with a unique specificity for 
an antigen that consists of a short peptide presented on 
class I MHC molecules by potential target cells (2). Upon 
encountering their cognate antigen, naïve CD8+ T cells 
become activated, undergo several rounds of cell division 
thereby generating clones of cells with the same receptor 
specificity, and differentiate to adopt a diverse multitude 
of specialized behaviors depending on the context of their 
activation (1). The factors that govern these cell fates 
include the abundance of peptide-MHC antigen, TCR 
affinity for the antigen, the presence or absence of co-
stimulatory signals, the local cytokine milieu, and cell-
intrinsic factors such as transcription factors and epigenetic 
regulators of gene expression.
Among the cell-intrinsic factors that regulate T cell 
differentiation are microRNAs (miRNAs). miRNAs are 
short (21–24 nucleotide) noncoding RNAs that post-
transcriptionally regulate target genes through interaction 
with their corresponding mRNAs (3). Functional expression 
of miRNAs is a complex process regulated by machinery 
that are regulated themselves, to an extent, by miRNAs (4). 
miRNAs are transcribed (mainly by RNA polymerase II) as 
long primary transcripts (pri-miRNAs) containing a hairpin 
structure that contains the mature miRNA sequence. 
These hairpins are cropped out of pri-miRNAs by the 
Microprocessor complex, consisting of the RNA binding 
protein DGCR8 and the RNase III family endoribonuclease 
Drosha, liberating precursor miRNAs (pre-miRNAs). Pre-
miRNAs are exported from the nucleus via exportin 5 where 
they become accessible to a second RNase III, Dicer, which 
removes the pre-miRNAs hairpin loop, generating a short 
RNA duplex. One strand of this duplex becomes a mature 
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miRNA upon its loading into an Argonaute (AGO) protein, 
forming a miRNA-induced silencing complex (miRISC) 
(3,4). The miRNA provides specificity to the miRISC, 
guiding AGO-mediated repression of target mRNAs via 
Watson-Crick base pairing between the miRNA “seed” 
sequence and “seed-match” sites found mainly within 
3'UTRs. In this manner, miRNAs facilitate translational 
repression as well as deadenylation and degradation of their 
target mRNAs.
Adding to the complexity of miRNA regulation, 
the expression of miRNAs, their target genes, and the 
machinery required for miRNA function varies between 
cell types and differentiation states. Therefore, the role of 
a particular miRNA in one cell type can be dramatically 
different than its role in another. Depending on the 
expression level of a particular miRNA and a target 
RNA, the miRNA may exert little to no effect on protein 
abundance, tune protein abundance to appropriate levels, 
or even reduce protein abundance beyond a threshold 
necessary for effective function in the cell (5). These 
properties endow miRNAs with the ability to confer 
robustness to biological processes (6), and to buffer noisy 
and stochastic transcription that can be leaky and occur in 
bursts (7-9). Mathematical modeling supported by single-
cell reporter assays confirmed a broad role for miRNAs in 
reducing noise in weakly expressed genes, while surprisingly 
increasing noise in highly expressed genes (10).
Like transcription factors, miRNAs mediate their 
biological functions through the regulation of networks of 
target genes. The magnitude of direct miRNA repression 
of an individual target mRNA and its corresponding 
protein is modest, almost never exceeding a two-fold effect. 
Nevertheless, individual miRNA:target interactions are 
biologically relevant, as suggested by the evolutionary 
conservation of many miRNA binding sequences, and 
supported by naturally occurring variants in miRNA 
binding sites that alter physiology or confer risk for 
pathology (11-13). In a few cases, the in vivo requirement 
for an individual miRNA:target interaction has been 
interrogated experimentally by mutating a binding sequence 
by gene targeting in mice (14-17). Each of these mutations 
was sufficient to produce a profound phenotype, yet none 
of them could account for the full effect of removing the 
miRNA entirely. Indeed, all of them involve mutating 
a single binding site for the same miRNA (miR-155) in 
different target genes. 
Exemplifying the broad nature of miRNA targeting, 
algorithms that take into account the conservation 
of miRNA seed-matches within 3'UTRs predict that 
over 60 percent of all RefSeq annotated genes can be 
regulated by one or more miRNAs (11). Biochemical 
methods that detect miRISC occupancy on mRNAs, 
s u c h  a s  A G O 2  h i g h - t h r o u g h p u t  s e q u e n c i n g  o f 
RNAs isolated by crosslinking immunoprecipitation 
(AGO2 HITS-CLIP or AHC) (18) and differential 
AHC, in which AHC data from cells sufficient or 
deficient for a particular miRNA are compared (19), 
generally support these predictions, but indicate that 
they likely underestimate the extent of miRNA:target 
interactions. Including all mRNAs with 3'UTR seed-
matches, regardless of conservation, expands the list of 
predicted miRNA targets to include over 98 percent of 
all RefSeq annotated genes (Figure 1A). Prediction based 
on sequence alone is not sufficient evidence that targeting 
occurs. However, it can guide biochemical analyses of 
miRNA binding to transcripts, as well as expression analyses 
that measure the context-specific functional effects of 
miRNAs. Comparative measurement of nascent and mature 
mRNA levels and quantitative proteomics showed that 
only 99 targets were stabilized by miR-144/451 deficiency 
in erythroblasts (20). AHC supported these findings by 
demonstrating that for most transcripts with miR-144/451-
dependent AGO2 binding, there was no appreciable 
stabilization in miR-144/451 deficient erythroblasts. Further 
work will be necessary to determine the generalizability of 
these findings among other miRNAs in different contexts. 
Importantly, a single RNA can be targeted by multiple 
miRNAs, and each miRNA influences the expression of 
tens to hundreds of direct target RNAs (Figure 1B). These 
targets often include sets of genes that function in common 
biological pathways, providing opportunities for miRNAs 
to produce additive phenotypic effects, and to control 
multiple potential limiting factors in noisy or dynamic gene 
expression programs. 
miRNAs are required for the normal behavior of almost 
every vertebrate cell type in which their biogenesis or 
function has been experimentally disabled. In this review, 
we focus on the regulatory mechanisms that govern 
CD8+ T cell fate and function within immune responses, 
emphasizing the roles of miRNAs in controlling or 
modulating these mechanisms. Additionally, we provide 
commentary on emergent principles of miRNA regulation.
miRNA regulation of CD8+ T cell function
In response to activation by their cognate antigen, T 
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cells adopt gene expression profiles conducive to rapid 
proliferation and the deployment of effector functions. While 
many of these changes occur at the transcriptional level, as 
much as 50 percent are mediated post-transcriptionally (21). 
miRNAs also exhibit profound changes in abundance 
in response to T cell activation owing at least in part to 
the rapid turnover of miRNA processing machinery and 
Argonaute proteins (22,23). miR-16, miR-142-3p, miR-150, 
miR-142-5p, miR-15b, and let-7f are the most abundantly 
expressed miRNAs in naïve CD8 T cells and all of these 
miRNAs are down-regulated with in vitro activation (24). 
Globally, the majority of miRNAs are immediately 
down-regulated in response to T cell activation (23). 
However, some, such as miR-155, are transcriptionally 
upregulated and increase in abundance during T cell 
activation (25-27).
Essential to an effective cytotoxic T cell response is the 
proliferation and accumulation of sufficient quantities of 
antigen-specific cells capable of killing infected cells and 
cancer. CD8+ T cells lacking miR-155 fail to appropriately 
expand in response to LCMV infection (28). In fact, in 
the absence of miR-155, there is a ten-fold reduction 
in antigen-specific CD8+ T cell accumulation (29) and 
this appears to be driven by miR-155 effects on both 
proliferation and survival (30). Members of the miR-17~92 
cluster of miRNAs are also up-regulated in response to 
CD8+ T cell activation in vivo (31,32). Consistent with 
previous reports describing lymphoproliferative disease 
resulting from overexpression of the miR-17~92 cluster (33), 
the proliferative capacity of antigen-specific CD8+ T cells 
is diminished in the absence of miR-17~92 (32). miR-
17~92 has been demonstrated to directly target the tumor 
suppressor PTEN and the pro-apoptotic protein Bim, 
providing at least two targets with shared functionality by 
which miR-17~92 may act. miR-15/16 has been shown to 
directly target a network of cell cycle and survival associated 
genes including Ccne1 and Bcl2 (34-36). Consistent with 
these observations, deletion of miR-15/16 results in 
increased proliferative capacity and survival among antigen-
specific CD8+ T cells (36,37).
Highlighting the importance of miRNAs in restraining 
CD8+ T cell effector function, Dicer-deficient CD8+ T cells 
exhibit increased production of perforin, granzyme B, and 
interferon-gamma (IFN-γ) (38). T cell migration out of 
central lymphoid organs is a critical component to effector 
responses and is mediated by surface expression of S1P1 
(39), which is inhibited by CD69 (40). Dicer-deficient 
CD8+ T cells are defective in their ability to migrate 
out of central lymphoid organs and fail to accumulate in 
response to infection, likely due to retained surface CD69 
Figure 1 MicroRNAs (miRNAs) target broad, overlapping networks of target genes to elicit phenotypes. (A) Characterization of RefSeq 
annotated genes with the potential for targeting by miRNAs based on TargetScan prediction algorithm or 3'UTR seed-match. (B) Schematic of 
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expression (41). Several miRNAs that participate in this 
restraint are downregulated upon T cell activation, linking 
activating signals to diminishment of a miRNA barrier to 
T cell differentiation and acquisition of effector functions. 
Naïve T cells strongly express several members of the 
let-7 family of miRNAs. Inhibiting let-7 production by 
overexpression of the regulatory RNA binding protein LIN-
28 leads to increased baseline CD8+ T cell proliferation (42). 
Conversely, let-7 overexpression inhibited antigen-specific 
T cell clonal expansion and effector function. Retroviral 
over-expression of pri-miRNAs revealed that miR-139-3p 
can lead to downregulation of perforin and the transcription 
factor EOMES, while miR-150 indirectly regulated 
expression of the high affinity interleukin (IL)-2 receptor, 
CD25 (38). miR-29 is also down-regulated in response to 
T cell activation, and is capable of regulating the expression 
of IFN-γ both directly (43) and indirectly by targeting the 
transcription factors, T-BET and EOMES (9).
On the other hand, miR-155 deficiency in CD8+ T cells 
results in reduced cytotoxicity (28) and effector cytokine 
production (29). In addition to its role in these effector 
functions, miR-155 enhances the responsiveness of CD8+ T 
cells to the homeostatic cytokines, IL-7 and IL-15 (44) as well 
as IL-2 (30). Socs1 knockdown rescues the decreased IL-2 
responsiveness of miR-155 deficient T cells. Additionally, 
Socs1 knockdown in CD8+ T cells phenocopies the tumor-
protective effect of miR-155 over-expression. However, while 
miR-155 plays a critical role in the responsiveness of CD8+ 
T cells in both acute and chronic infection models, target 
site mutation indicated that Socs1 repression by miR-155 
is only sufficient to mediate a measurable effect in chronic 
models (17). In addition to Socs1, miR-155 represses Ship1 
and Ptpn2, two other negative regulators of AKT and STAT5 
signaling (44), among many other direct target mRNAs (19). 
Overexpression of miR-155 leads to a remarkably improved 
anti-tumor response by tumor-specific CD8+ T cells (30) 
suggesting that this approach may be beneficial in adoptive 
T cell therapies for cancer. The carefully dissected biology of 
miR-155 in T cell responses provides an edifying example of 
how miRNAs mediate pleiotropic effects through regulation 
of a network of target genes.
miRNA regulation of CD8+ T cell memory
In response to infection or cancer, antigen-specific CD8+ T 
cells may take on the properties of terminally differentiated 
effector (TE) cells armed with the ability to find and kill 
infected or abnormal cells, or those of memory precursor 
(MP) cells capable of persisting long after antigen clearance 
to provide protection from future encounters. In mice, TE 
and MP cells can be distinguished early in the immune 
response based on their surface expression of killer cell 
lectin like receptor G1 (KLRG1) (45) or the IL-7 receptor 
alpha chain, CD127 (46), respectively. 
A single naïve CD8+ T cell has the potential to give 
rise to both TE and MP cells (47-49). Asymmetric cell 
division occurs during clonal selection of antigen-specific 
T cells, providing one plausible mechanism by which a 
single antigen-specific T cell could give rise to daughters 
with differing predetermined lineage fates (50). Noisy 
expression of lineage-determining factors may also promote 
stochasticity in these lineage decisions. Responding T 
cells exhibit a great deal of heterogeneity with respect 
to proliferative capacity, cytokine production, and the 
expression of KLRG1 and CD127, and these properties 
can be intrinsically biased by the TCR even as they are 
regulated by external cues (51). 
No single master transcription factor regulates the 
differentiation of TE and MP cells, but many contributing 
factors have been identified. Positive regulators of MP 
cell differentiation include EOMES (52), TCF1 (53), 
ID3 (54,55), BCL-6 (56), STAT3 (56), FOXO1 (57,58), 
BACH2 (59), and MYB (60). Those found to bias cells 
towards TE fate include T-BET (45,61), BLIMP-1 (62,63), 
ID2 (50), STAT4 (64), and ZEB2 (65,66). Given that most 
of these lineage-biasing transcription factors only differ by 
approximately two-fold in their expression across TE and 
MP populations, it is likely that the fate of an activated 
CD8+ T cell is driven by the integration of their effects on 
downstream target gene networks (50).
Among memory CD8+ T cells, there is a great deal 
of further heterogeneity. T central memory (Tcm) cells, 
marked by high expression of CD127, CD62L, CD27, 
CXCR3, and CCR7, are more proliferative in response 
to antigen re-challenge. In addition, they tend to exhibit 
polyfunctionality with respect to effector cytokine secretion, 
producing IL-2, IFN-γ, and TNF. Conversely, they tend to 
express lower levels of the cytotoxin granzyme B. Due to 
their expression of the homing molecules CD62L, CXCR3, 
and CCR7, Tcm cells circulate through secondary lymphoid 
organs (SLOs), enhancing their probability of encountering 
antigen presenting cells (APCs) displaying their cognate 
antigen. CD27 is a member of the tumor necrosis factor 
receptor superfamily that acts as a co-stimulatory molecule 
on Tcm cells, but is absent from TE populations (67). Tcm 
cells provide superior anti-tumor immunity (68,69) and 
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protection against re-infection with virus (70,71). T effector 
memory (Tem) populations express high levels of CD127, 
but little or no CD62L, CXCR3, CD27, and CCR7. 
Instead, they often express chemotactic and adhesion 
molecules that allow entry into peripheral, non-lymphoid 
tissues while excluding them from SLOs. Functionally, Tem 
cells have enhanced killing capacity due to high expression 
of the inflammatory cytokines IFN-γ and TNF, as well as 
the cytotoxic molecules, perforin and granzyme B. 
Defining the roles of miRNAs in TE and MP regulation 
is an active area of research. Several individual miRNAs, 
or families of miRNAs with identical seed sequences, are 
known to promote TE or MP differentiation. For example, 
we recently found that the abundant miR-15/16 family 
restricts the accumulation of MP cells (36). T cells lacking 
miR-15/16 exhibit early and sustained increases in MP cell 
production during the course of viral infection. In wildtype 
T cells, miR-15/16 bind and repress the expression of 
hundreds of target genes. Among these targets are a sizable 
network of memory cell associated genes, including Il7r, 
which encodes CD127. CD127 is required for the long-
term survival of memory cells (72), and IL-7 availability 
can limit memory cell formation (73). Thus, miR-15/16 
may restrict MP differentiation, proliferation and survival 
in part by tuning their expression of CD127. However, 
even transgenic over-expression of CD127 is insufficient to 
enforce memory cell differentiation (72), consistent with 
the expectation that others among the large number of 
potentially relevant miR-15/16 targets contribute to this 
phenotype (36). Of note, transfection of CD8+ T cells with 
miR-15b mimics led to reduced apoptosis in response to 
stimulation with anti-CD3 in vitro and was attributed to the 
down-regulation of the programmed cell death-mediator, 
DEDD (74). These seemingly conflicting findings among 
in vivo and in vitro systems highlight the context-dependent 
nature of miRNA biology in T cells.
At the lower limits of gene expression, the fine tuning 
function of miRNAs can effectively enforce the silencing of 
genes with very low or leaky transcription (75). For example, 
miR-29 regulates IFN-γ production by Dicer-deficient CD4 
T cells in part by silencing Eomes, a gene that can co-opt a 
transcriptional program usually enacted by another miR-29 
target, T-BET (9). miR-29 overexpression in CD8 T cells 
reduces KLRG1+ TE cell production while boosting the 
frequency of MP cells (9). miR-15/16 may help to enforce 
silencing of CD127 expression in TE cells, providing 
robustness to the restriction of IL-7 responsiveness to MP 
cells. CD127 is maintained at low levels in TE cells via GFI-
1 mediated transcriptional silencing (76).
miR-155 increases CD8+ T cell sensitivity to the common 
gamma chain receptor signaling cytokines, IL-7, IL-15, 
and IL-2 (30,44). As such, one might predict miR-155 to 
be a positive regulator of MP cell accumulation. Yet miR-
155 is down-regulated in response to in vitro culture of 
CD8+ T cells with IL-15, and miR-155 deficiency boosts 
the frequency of CD127+ CD62L+ IL-2 producing MP 
cells in response to infection with murid herpesvirus (77). 
In LCMV infection, miR-155 deficiency disrupts the 
formation of both MP and TE populations, while miR-155 
over-expression enhances accumulation of Tem cells (78). 
Similar observations were reported by several groups, 
though their attribution of these phenotypes to direct 
miR-155 target genes varied. SHIP-1 was particularly 
implicated for its role in the negative regulation of AKT 
phosphorylation and T-BET expression (28). However, 
once again it appears likely that miR-155 acts through a 
network of targets with additive or synergistic cell intrinsic 
effects on antiviral CD8+ T cell responses (29).
The transcription factors ZEB1 and ZEB2 play reciprocal 
roles in the promotion of MP and TE cell differentiation 
respectively (79). ZEB2 is expressed among terminally 
differentiated cytotoxic T cells in a T-bet-dependent 
manner and plays a critical role in the suppression of MP 
associated genes while positively regulating TE-associated 
genes (65,66). Although the miR-200 family of miRNAs have 
been shown to negatively regulate both Zeb1 and Zeb2 in the 
context of epithelial differentiation (80), only Zeb2 mRNA 
appears to interact with, and be efficiently targeted by, miR-
200 family miRNAs in T cells. Consistent with these findings, 
miR-200 was essential for normal memory CD8+ T cell 
differentiation (79). This study documents the importance 
of cellular context to miRNA-target interactions, further 
highlighting the utility of empirical target identification by 
co-immunoprecipitation with AGO proteins.
Metabolism plays a critical role in the proliferation and 
differentiation of CD8+ T cells. Inhibition of mTOR, for 
example, enhances memory cell persistence through the 
switch from glycolysis to fatty acid metabolism (81,82) and 
through the regulation of T-BET and EOMES (83). Over-
expression of the miR-17~92 cluster of miRNAs enhances 
TE differentiation, while miR-17~92 deficient CD8+ T 
cells are biased towards a MP phenotype (32). miR-17~92 
regulates PI3K-AKT-mTOR signaling in T cells, and many 
other cell types, by targeting PTEN, a tightly tuned lipid 
and protein phosphatase that counteracts this signaling axis. 
These results do not rule out other targets as players. In fact, 
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miR-17~92 also downregulates additional negative regulators 
of mTOR (e.g., Pdcd1, Btla, and Fcgr2b), though direct 
targeting and functional relevance of these putative targets 
has not been confirmed (31). The importance of functional 
testing of targets and consideration of the full suite of targets 
of a miRNA is highlighted by the case of mir-15/16, which 
regulates both mTOR and Rictor (37,84), but nevertheless 
restricts, rather than enhances, memory cell differentiation.  
In human CD8+ T cells, miR-143 overexpression 
enhanced the production of cells expressing the memory 
markers CD127, CD27 and CD28, whereas miR-143 
inhibition reduced them (85). These effects were attributed 
to the miR-143 target Glut1, whose knockdown produced 
a phenotype consistent with that produced by miR-143 
overexpression. The rate-limiting glycolysis enzyme HK2 
was also down-regulated upon miR-143 overexpression (85), 
consistent with previous reports of direct targeting by miR-
143 (86). Thus miR-143 coordinates the expression of at 
least two key targets in a pathway (glycolytic metabolism) 
critical to the regulation of CD8+ T cell responses.
The roles of miRNAs in the transitions between memory 
cell states remains poorly understood. Transfer of CD62Lhi 
and CD62Llo antigen-specific CD8+ T cells supports a 
model of linear transition from naïve to Tem to Tcm cell 
identities (70). And KLRG1+ CD127+ Tem cells can lose 
KLRG1 expression and seed Tcm cell compartments in a 
Bach2-dependent manner (87). While over-expression of 
miR-150 decreases CD127+ CXCR3+ Tcm populations, 
subsequent reduced expression at later timepoints leads 
to an increase in Tcm cells (88). In some systems, miR-
150 deficient memory T cells remained defective in recall 
responses and cytolytic function (89). Overexpression of 
the miR-150 target MYB was sufficient to partially rescue 
some of the memory cell defects associated with miR-150 
over-expression (88). This may be at least in part attributable 
to the indispensable role of MYB in regulating CD8+ T 
cell stemness, memory, and polyfunctionality (60). Another 
study confirmed that miR-150 restrains memory CD8+ T 
cell differentiation but attributed these effects to another 
direct target, Foxo1, a transcription factor that drives memory 
cell differentiation through induction of TCF1 (90). The 
established miR-150 target network contains several other 
functionally relevant target genes, including Trp53 (91), 
Slc2a1 (92), Mtor (93), Ptrx7 (94), Egr2 (95), in addition to 
indirect effects on CD25 expression (38).
miRNA regulation of CD8+ T cell exhaustion
Effective memory generation requires the clearance of the 
pathogen or tumor. Persistent antigen exposure induces 
CD8+ T cell “exhaustion”, characterized by upregulation of 
inhibitory receptors including PD1, LAG3, and CTLA4, 
concomitant with reduced proliferation capacity, effector 
function and cell survival (96). Understanding the drivers 
and maintainers of T cell exhaustion is especially pressing 
in the context of tumor immunology. Over the two past 
decades, it has become evident that the reversal of T cell 
exhaustion can unleash existing tumor-specific cytotoxic T 
cells to attack and kill cancerous cells. Blocking inhibitory 
receptors can reverse exhaustion and induce productive 
antiviral and antitumor immunity (97-99). PD-1 blockade 
only temporarily reinvigorates exhausted CD8+ T cells if 
the causative antigen is not cleared, indicating that targeting 
these surface receptors alone may be insufficient for many 
immunotherapies (100). Effective strategies for durably 
reprogramming exhausted T cells may improve existing and 
developing immunotherapies for cancer.
A growing number of transcription factors have been 
implicated in T cell exhaustion including T-BET, EOMES, 
Spry2, BLIMP-1, VHL, FOXO1, IRF, BATF, and NFATC1 
(96,101) and more recently, the NR4A family members, 
NR4A1, NR4A2, and NR4A3 (102). Interestingly, 
many of these transcription factors are also critical to 
functional effector and memory CD8+ T cells, suggesting 
a complexity to the drivers of exhaustion that remains 
to be fully understood. For example, IRF4 and BATF 
are essential for CD8+ T cell effector function during 
infection with LCMV (103), but they can also elevate 
PD-1 expression and repress TCF1, thereby promoting 
exhaustion while inhibiting memory formation (101). 
miRNAs also play a role in CD8+ T cell exhaustion. In 
the context of cancer, tumor-derived TGF-β can lead to 
elevation of miR-23a expression, thereby downregulating 
BLIMP-1 and a loss of effector function (104). Functional 
inhibition of miR-23a led to improved effector function 
and a more durable response to established tumors. In 
response to chronic infection with LCMV clone 13, miR-31 
deficient CD8+ T cells express reduced levels of exhaustion 
markers and retain characteristics of effector cells, including 
production of cytotoxins and cytokines (105). Mice lacking 
miR-31 expression only in T cells were protected from the 
wasting associated with chronic infection and harbored 
lower viral titers. miR-155 overexpression enhances the 
persistence of exhausted CD8+ T cells during chronic 
infection (106). Uncoupling persistence from effector 
function, miR-155 overexpression fails to restore cytokine 
production and cytotoxic potential, and actually increases 
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inhibitory receptor expression in these cells. Unlike 
memory cells, exhausted CD8+ T cells do not require the 
homeostatic cytokines IL-7 and IL-15 to persist and instead 
rely on constant exposure to their cognate antigen (107). 
Thus, miR-155’s ability to alter CD8+ T cell sensitivity 
to common gamma chain cytokine receptor signals is 
unlikely to be responsible for increased persistence of miR-
155-overexpressing exhausted T cells. Conversely, in the 
chronic setting of cancer, miR-155 overexpression delays 
CD8+ T cell contraction, prolongs cytokine production, 
and increases their sensitivity to common gamma chain 
cytokines (44). miR-31 may reduce exhaustion in part by 
increasing CD8+ T cell sensitivity to type I IFNs (105). 
However, miR-155 decreases IFN sensitivity (29), so this 
is also unlikely to play a role in the persistence of miR-
155 overexpressing exhausted T cells. The varied effects of 
miR-155 on T cells responses to acute and chronic infection 
as well as cancer highlight the context specific nature of 
miRNAs regulation of immunity.
Perspective
miRNAs are important regulators of CD8+ T cell function 
in host defense, infection, and cancer immunosurveillance. 
They regulate almost every aspect of CD8+ T cell behavior 
from survival and proliferation, to the acquisition and 
deployment of effector functions, to fate decisions that 
dictate the formation of immunological memory and 
tolerance. Individual miRNA-target interactions can have 
profound impacts on cell behavior, but mounting evidence 
indicates that miRNAs mediate context-specific biological 
effects by binding and tuning the expression of large 
networks of target genes. There remains much to learn 
about miRNA regulation in CD8+ T cells, and perhaps even 
more to learn about CD8+ T cell programming from the 
study of miRNAs. While somewhat useful in the validation 
of target sites, assays that remove the 3'UTRs of putative 
target genes from their endogenous context (e.g., luciferase 
assays) suffer from a potential for both false-positive and 
false-negative findings. Furthermore, the singling out of 
individual targets and the highlighting of the capacity for 
their 3'UTRs to be regulated by a particular miRNA draws 
attention away from the underlying nature of miRNAs as 
network regulators of gene circuits. The field of miRNA 
biology will benefit greatly from a more systematic 
identification of miRNA targets within each cellular context 
and formulating a catalog of the pathways and gene sets 
involved. To this end, future studies should expand on 
efforts to map the full target repertoire of functionally 
relevant miRNAs using a combination of bioinformatics, 
biochemistry (AHC), and analysis of endogenous miRNA 
effects on gene expression in biologically relevant contexts. 
These target-agnostic approaches invite the discovery of 
novel targets and will lead to better assessment of how their 
associated pathways integrate with phenotype. 
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